Mobile Magnetic Nanocatalysts for Bioorthogonal Targeted Cancer Therapy

The authors would like to acknowledge the Scientific Center for Optical and Electron Microscopy (ScopeM) of ETH, and the FIRST laboratory for their technical support. The authors would also like to acknowledge to the Histology and Electron Microscopy Service (HEMS) core facility at i3S - Instituto de Investigacao e Inovacao em Saude, University of Porto - specially to Rui Fernandes for the TEM analysis. The authors also acknowledge the pathologist Antonio Polonia for the immunohistological classification of mice tumors. This work partially financed by the European Research Council Starting Grant “Magnetoelectric Chemonanorobotics for Chemical and Biomedical Applications (ELECTROCHEMBOTS),” by the ERC Grant agreement no. 336456. This work was further supported by the Short-Term Scientific Mission (STSM) Grant from the COST Action MP1407. and the NORTE-01-0145-FEDER-000012 project, financed by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF). Animal experiments were carried out in accordance with the European Guidelines for the Care and Use of Laboratory Animals, Directive 2010/63/UE and the National Regulation published in 2013 (Decreto-Lei n.° 113/2013 de 7 de Agosto). All experimental procedures were approved by the Ethics Committee of i3S.

[1]  B. Nelson,et al.  A smart multifunctional drug delivery nanoplatform for targeting cancer cells. , 2016, Nanoscale.

[2]  John C. Dawson,et al.  Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach , 2014, Nature Communications.

[3]  B. Testa,et al.  Lessons learned from marketed and investigational prodrugs. , 2004, Journal of medicinal chemistry.

[4]  P. Simmonds,et al.  Corrigendum: Exploration of acetanilide derivatives of 1-(ω-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replication , 2016, Scientific reports.

[5]  C. Bertozzi,et al.  From Mechanism to Mouse: A Tale of Two Bioorthogonal Reactions , 2011, Accounts of chemical research.

[6]  M. Finn,et al.  Click chemistry in complex mixtures: bioorthogonal bioconjugation. , 2014, Chemistry & biology.

[7]  Kinam Park,et al.  Facing the truth about nanotechnology in drug delivery. , 2013, ACS nano.

[8]  J. Peterse,et al.  Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.

[9]  Sung Tae Kim,et al.  Supramolecular regulation of bioorthogonal catalysis in cells using nanoparticle-embedded transition metal catalysts. , 2015, Nature chemistry.

[10]  Jun Du,et al.  Experimental characterization of electrochemical synthesized Fe nanowires for biomedical applications , 2012 .

[11]  Peng R. Chen,et al.  Palladium-triggered deprotection chemistry for protein activation in living cells. , 2014, Nature chemistry.

[12]  G. Poon,et al.  Prodrug Applications for Targeted Cancer Therapy , 2014, The AAPS Journal.

[13]  Phuong Dinh,et al.  Review: side effects of approved molecular targeted therapies in solid cancers. , 2007, The oncologist.

[14]  E. Meggers,et al.  Progress towards bioorthogonal catalysis with organometallic compounds. , 2014, Angewandte Chemie.

[15]  B. Chabner,et al.  Chemotherapy and the war on cancer , 2005, Nature Reviews Cancer.

[16]  Yan Dai,et al.  Freestanding palladium nanosheets with plasmonic and catalytic properties. , 2011, Nature nanotechnology.

[17]  Paul C. Wang,et al.  Circumventing tumor resistance to chemotherapy by nanotechnology. , 2010, Methods in molecular biology.

[18]  Martin Pumera,et al.  Fabrication of Micro/Nanoscale Motors. , 2015, Chemical reviews.

[19]  John C. Dawson,et al.  N-alkynyl derivatives of 5-fluorouracil: susceptibility to palladium-mediated dealkylation and toxigenicity in cancer cell culture , 2014, Front. Chem..

[20]  Mark J. Ratain,et al.  Pharmacokinetic variability of anticancer agents , 2005, Nature Reviews Cancer.

[21]  M. Ismail,et al.  International Journal of Biological Sciences , 2009 .

[22]  B. Woodward Palladium in Temporary and Permanently Implantable Medical Devices , 2012 .

[23]  John C. Dawson,et al.  Development and Bioorthogonal Activation of Palladium-Labile Prodrugs of Gemcitabine , 2014, Journal of medicinal chemistry.

[24]  Jeffrey A. Engelman,et al.  Prospects for combining targeted and conventional cancer therapy with immunotherapy , 2017, Nature Reviews Cancer.

[25]  Jiye Shi,et al.  Smart Drug Delivery Nanocarriers with Self‐Assembled DNA Nanostructures , 2013, Advanced materials.

[26]  S. Pané,et al.  Hybrid Magnetoelectric Nanowires for Nanorobotic Applications: Fabrication, Magnetoelectric Coupling, and Magnetically Assisted In Vitro Targeted Drug Delivery , 2017, Advanced materials.

[27]  V. Gandhi,et al.  ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage. , 2012, Therapeutic delivery.

[28]  N. Myung,et al.  Electrochemically fabricated zero-valent iron, iron-nickel, and iron-palladium nanowires for environmental remediation applications. , 2007, Water science and technology : a journal of the International Association on Water Pollution Research.

[29]  Joseph Wang,et al.  Micro/nanorobots for biomedicine: Delivery, surgery, sensing, and detoxification , 2017, Science Robotics.

[30]  S. Chankeshwara,et al.  Palladium-mediated chemistry in living cells. , 2014, Current opinion in chemical biology.

[31]  M. Cecchini,et al.  Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease , 2016, Scientific Reports.

[32]  S. Peters,et al.  Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases. , 2014, Cancer treatment reviews.

[33]  V. Macdonald Chemotherapy: managing side effects and safe handling. , 2009, The Canadian veterinary journal = La revue veterinaire canadienne.

[34]  P. Couvreur,et al.  Palladium: a future key player in the nanomedical field? , 2015, Chemical science.

[35]  Pep Pàmies,et al.  Materials for drug delivery. , 2013, Nature materials.

[36]  Tycho Heimbach,et al.  Prodrugs: design and clinical applications , 2008, Nature Reviews Drug Discovery.

[37]  R. Freitas Pharmacytes: an ideal vehicle for targeted drug delivery. , 2006, Journal of nanoscience and nanotechnology.

[38]  P. Sinko,et al.  Recent trends in targeted anticancer prodrug and conjugate design. , 2008, Current medicinal chemistry.